Skip to main content
Log in

Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life after Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Sarcopenic obesity may affect the health outcome of people with obesity after laparoscopic sleeve gastrectomy (LSG). To assess the impact of sarcopenic obesity (SO) on weight loss outcomes and improvement of quality of life after LSG.

Materials and Methods

This observational study included patients who underwent LSG with SO (99 patients) or without SO (146 patients) from a single center. The primary endpoint was weight loss and disease-specific quality of life in patients with or without SO after the operation. Fat-free mass (FFM) and fat mass (FM) were calculated based on the L3-level images of preoperative CT scans. SO was diagnosed if FM/FFM ≥ 0.80.

Results

Operative time and postoperative hospital stay days were longer in the SO group (p < 0.001). After LSG, weight, BMI, and EBMI were significantly lower in the NSO group than in the SO group (all P < 0.05), while %EWL and the number of patients with %EWL ≥ 100% were significantly lower in the SO group (both p < 0.05). The total BAROS scores of patients in the NSO group were higher than those in the SO group (p < 0.05). Additionally, the MA II questionnaire assessment showed a lower percentage of “very good” and “good” outcomes in the SO group (p < 0.05).

Conclusions

Patients with SO take a slower rate, longer time to reach the ideal weight, and lower quality of life self-ratings than NSO patients after LSG. Thus, preoperative evaluation and tailoring rehabilitation guidance for people with SO should be accounted.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Lin JX and Huang CM had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis.

Abbreviations

LSG :

Laparoscopic sleeve gastrectomy

NSO :

No sarcopenic obesity

SO :

Sarcopenic obesity

FM :

Fat mass

FFM :

Fat-free mass

FM/FFM :

Fat mass to fat-free mass ratio

SMA :

Skeletal muscle area

%EWL :

Percentage of excess weight loss

%TWL :

Percentage of total weight loss

%WL :

Percentage of weight loss

BAROS :

Bariatric analysis and reporting outcome system

RBC :

Red blood cell

Hb :

Hemoglobin

VitB12 :

Vitamin B12

25-VitD :

25-Hydroxyvitamin D

Vit A :

Vitamin A

VitE :

Vitamin E

ALB :

Albumin

TG :

Triglyceride

CHOL :

Cholesterol

HDL-C :

High-density lipoprotein cholesterol

LDL-C :

Low-density lipoprotein cholesterol

BUN :

Blood urea nitrogen

CR :

Creatinine

UA :

Uric acid

ALT :

Alanine aminotransferase

AST :

Aspartate aminotransferase

AST/ALT :

Ratio of aspartate aminotransferase to alanine aminotransferase

VAT :

Visceral adipose tissue

SAT :

Subcutaneous adipose tissue

IMAT :

Intermuscular adipose tissue

SMI :

Skeletal muscle index

VAI :

Visceral adipose index

SAI :

Subcutaneous adipose index

HU :

Hounsfield unit

References

  1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. https://doi.org/10.1056/NEJMoa1614362.

  2. Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA: Cancer J Clin. 2019;69(2):88–112.

    PubMed  Google Scholar 

  3. Panagiotou OA, Markozannes G, Adam GP, et al. Comparative effectiveness and safety of bariatric procedures in medicare-eligible patients: a systematic review. JAMA Surg. 2018;153(11):e183326.

    Article  PubMed  Google Scholar 

  4. Biter LU, Gadiot RP, Grotenhuis BA, et al. The sleeve bypass trial: a multicentre randomized controlled trial comparing the long-term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obes. 2015;2:30 (published 2015 Aug 26).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yip C, Dinkel C, Mahajan A, et al. Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging. 2015;6(4):489–97.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hsu KJ, Liao CD, Tsai MW, et al. Effects of exercise and nutritional intervention on body composition, metabolic health, and physical performance in adults with sarcopenic obesity: a meta-analysis. Nutrients. 2019;11(9):2163 (Published 2019 Sep 9).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Thibault R, Genton L, Pichard C. Body composition: why, when and for who ? Clin Nutr (Edinburgh, Scotland). 2012;31(4):435–47.

    Article  Google Scholar 

  8. Batsis JA, Barre LK, Mackenzie TA, et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc. 2013;61(6):974–80.

    Article  PubMed  Google Scholar 

  9. Prado CM, Wells JC, Smith SR, et al. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr (Edinburgh, Scotland). 2012;31(5):583–601.

    Article  CAS  Google Scholar 

  10. Kim YS, Lee Y, Chung YS, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol Ser A, Biol Sci Med Sci. 2012;67(10):1107–13.

    Article  Google Scholar 

  11. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.

    Article  PubMed  Google Scholar 

  12. Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl_2):ii1–9.

    Article  CAS  PubMed  Google Scholar 

  13. Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2013;20(1):1–10.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Dhana K, Koolhaas CM, Schoufour JD, et al. Association of anthropometric measures with fat and fat-free mass in the elderly: the Rotterdam study. Maturitas. 2016;88:96–100.

    Article  PubMed  Google Scholar 

  16. Liu P, Ma F, Lou H, et al. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013;13:629.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Low S, Goh KS, Ng TP, et al. The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore. Clin Nutr. 2020;39(7):2274–81.

    Article  PubMed  Google Scholar 

  18. Jones K, Gordon-Weeks A, Coleman C, et al. Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis. World J Surg. 2017;41(9):2266–79.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg Open. 2021;37:100430.

    Article  Google Scholar 

  20. Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead-Ardelt quality of life questionnaire II. Obes Surg. 2003;13(5):684–92.

    Article  PubMed  Google Scholar 

  21. Carandina S, Montana L, Danan M, et al. Laparoscopic sleeve gastrectomy learning curve: clinical and economical impact. Obes Surg. 2019;29(1):143–8.

    Article  PubMed  Google Scholar 

  22. Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008;158(2):135–45.

    Article  CAS  PubMed  Google Scholar 

  23. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl physiol. 2004;97(6):2333–8.

    Article  PubMed  Google Scholar 

  24. Henninger HB, Christensen GV, Taylor CE, et al. The muscle cross-sectional area on MRI of the shoulder can predict muscle volume: an MRI study in cadavers. Clin Orthop Relat Res. 2020;478(4):871–83.

    Article  PubMed  Google Scholar 

  25. Dennis RA, Long DE, Landes RD, et al. Tutorial for using SliceOmatic to calculate thigh area and composition from computed tomography images from older adults. PLoS ONE. 2018;13(10):e0204529.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85(1):115–22.

    Article  CAS  PubMed  Google Scholar 

  27. Grimm A, Meyer H, Nickel MD, et al. Repeatability of Dixon magnetic resonance imaging and magnetic resonance spectroscopy for quantitative muscle fat assessments in the thigh. J Cachex Sarcopenia Muscle. 2018;9(6):1093–100.

    Article  Google Scholar 

  28. Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.

    Article  PubMed  Google Scholar 

  29. Oria HE, Moorehead MK. Updated bariatric analysis and reporting outcome system (BAROS). Surg Obes Relat Dis. 2009;5(1):60–6.

    Article  PubMed  Google Scholar 

  30. Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead-Ardelt quality of life questionnaire II. Obes Surg. 2003;13(5):684–92.

    Article  PubMed  Google Scholar 

  31. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93.

    Article  CAS  PubMed  Google Scholar 

  32. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age age ageing. 2010;39(4):412–23.

    Article  PubMed  Google Scholar 

  34. Mei KL, Batsis JA, Mills JB, et al. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Perioper Med. 2016;5:30.

    Article  Google Scholar 

  35. Hong HC, Hwang SY, Choi HY, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean sarcopenic obesity study. Hepatology. 2014;59(5):1772–8.

    Article  CAS  PubMed  Google Scholar 

  36. Heber D, Ingles S, Ashley JM, et al. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am J Clin Nutr. 1996;64(3 Suppl):472S-477S.

    Article  CAS  PubMed  Google Scholar 

  37. Coleman KJ, Basu A, Barton LJ, et al. Remission and relapse of dyslipidemia after vertical sleeve gastrectomy vs Roux-en-Y gastric bypass in a racially and ethnically diverse population. JAMA Netw Open. 2022;5(9):e2233843 (Published 2022 Sep 1).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Low S, Goh KS, Ng TP, et al. The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore. Clin Nutr (Edinburgh, Scotland). 2020;39(7):2274–81.

    Article  Google Scholar 

  39. Batsis JA, Mackenzie TA, Jones JD, et al. Sarcopenia, sarcopenic obesity and inflammation: results from the 1999–2004 National Health and Nutrition Examination Survey. Clin Nutr (Edinburgh, Scotland). 2016;35(6):1472–83.

    Article  PubMed Central  Google Scholar 

  40. Jones K, Gordon-Weeks A, Coleman C, et al. Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis. World J Surg. 2017;41(9):2266–79.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005;115(6):1119–29.

    Article  CAS  PubMed  Google Scholar 

  42. Romano L, Necozione S, Cianca G, et al. Weight loss after sleeve gastrectomy in patients with diabetes: preliminary study in one year of activity. Eur Rev Med Pharmacol Sci. 2021;25(12):4317–24. https://doi.org/10.26355/eurrev_202106_26139.

    Article  CAS  PubMed  Google Scholar 

  43. Yin X, Qian J, Wang Y, et al. Short-term outcome and early effect on blood pressure of laparoscopic sleeve gastrectomy in morbidly obese patients. Clin Exp Hypertens. 2019;41(7):622–6. https://doi.org/10.1080/10641963.2018.1529775.

    Article  CAS  PubMed  Google Scholar 

  44. Hans PK, Guan W, Lin S, et al. Long-term outcome of laparoscopic sleeve gastrectomy from a single center in mainland China. Asian J Surg. 2018;41(3):285–90. https://doi.org/10.1016/j.asjsur.2017.04.003.

    Article  PubMed  Google Scholar 

  45. Hirth DA, Jones EL, Rothchild KB, et al. Laparoscopic sleeve gastrectomy: long-term weight loss outcomes. Surg Obes Relat Dis. 2015;11(5):1004–7. https://doi.org/10.1016/j.soard.2015.02.016.

    Article  PubMed  Google Scholar 

  46. Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86.

    Article  PubMed  Google Scholar 

  47. Xu G, Song M. Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. Surg Obes Relat Dis. 2021;17(1):231–8.

    Article  PubMed  Google Scholar 

  48. Manoy P, Anomasiri W, Yuktanandana P, et al. Elevated serum leptin levels are associated with low vitamin D, sarcopenic obesity, poor muscle strength, and physical performance in knee osteoarthritis. Biomarkers. 2017;22(8):723–30.

    Article  CAS  PubMed  Google Scholar 

  49. Papamargaritis D, le Roux CW. Do gut hormones contribute to weight loss and glycaemic outcomes after bariatric surgery? Nutrients. 2021;13(3):762.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494 (Published 2020 Jan 13).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Shetty GK, Matarese G, Magkos F, et al. Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet. Eur J Endocrinol. 2011;165(2):249–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Janik MR, Rogula T, Bielecka I, et al. Quality of life and bariatric surgery: cross-sectional study and analysis of factors influencing outcome. Obes Surg. 2016;26(12):2849–55.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Major P, Matłok M, Pędziwiatr M, et al. Quality of life after bariatric surgery. Obes Surg. 2015;25(9):1703–10.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Chuffart E, Sodji M, Dalmay F, et al. Long-term results after sleeve gastrectomy for gastroesophageal reflux disease: a single-center French study. Obes Surg. 2017;27(11):2890–7.

    Article  PubMed  Google Scholar 

  55. Leivonen MK, Juuti A, Jaser N, et al. Laparoscopic sleeve gastrectomy in patients over 59 years: early recovery and 12-month follow-up. Obes Surg. 2011;21(8):1180–7.

    Article  PubMed  Google Scholar 

  56. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–37.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the bariatric and metabolic patients whose data were used for this study, without whom the work would not be possible. We extend our sincere appreciation to Prof. Feng-Qiong Liu of Fujian Medical University whose invaluable expertise in statistical analysis greatly contributed to the robustness and reliability of the findings presented in this study. Thanks to Dr. Zhi-Hong Huang of the Public Technology Service Center, Fujian Medical University.

Funding

This study was supported by the Financial Support for the Construction of “Dual High Medical Services in Fujian Province” (Min Wei Yi Zheng [2021] no. 76). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

Drs. Shang-Guan ZX, Lin GT, and Liu ZY contributed equally to this work and should be considered co-first authors. Drs Lin JX and Huang CM had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Shang-Guan ZX, Lin GT, Liu ZY, Zheng CH, Huang CM, and Lin JX. Acquisition, analysis, and interpretation of data: Shang-Guan ZX, Lin GT, Liu ZY, Zhong Q, Li P, Xie JW, Lu J, Wang JB, Chen QY, Cao LL, Lin M, Zheng HL, Zheng CH, Huang CM, and Lin JX. Drafting of the manuscript: Shang-Guan ZX, Lin GT, Liu ZY, Huang CM, and Lin JX. Critical revision of the manuscript for important intellectual content: Shang-Guan ZX, Lin GT, Liu ZY, Zhong Q, Li P, Xie JW, Lu J, Wang JB, Chen QY, Cao LL, Lin M, Zheng HL, Zheng CH, Huang CM, and Lin JX. Statistical analysis: Shang-Guan ZX, Lin GT, Liu ZY, Huang CM, and Lin JX. Obtained funding: Shang-Guan ZX, Lin GT, Liu ZY, Huang CM, and Lin JX. Administrative, technical, and material support: Zhong Q, Li P, Xie JW, Lu J, Wang JB, Chen QY, Cao LL, Lin M, Zheng HL, and Zheng CH. Supervision: Zhong Q, Li P, Xie JW, Lu J, Wang JB, and Chen QY.

Corresponding author

Correspondence to Chang-Ming Huang.

Ethics declarations

Ethical Approval

This study passed and was approved by the Fujian Medical University Union Hospital institutional review board (IRB number 2023KY068). Due to the retrospective and observational design, the IRB waived the need for informed consent for this study. For this type of study formal consent is not required.

Informed Consent

Participants were informed of the study’s purpose, procedures, potential risks and benefits, and their right to withdraw from the study at any time without penalty. The data collected were kept confidential and used solely for research purposes. For any identifiable human images or other personal information included in this manuscript, the corresponding author has secured written informed consent from the individuals. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Consent for Publication

Patients signed informed consent regarding publishing their data.

Conflict of Interest

The authors declare no competing interests.

Additional information

Provenance and peer review

Not commissioned, Externally peer-reviewed.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• SO group exhibited longer operative time and postoperative hospital stay. The NSO group showed significantly lower weight, BMI, and EBMI compared to the SO group.

• SO affects health outcomes after LSG, and assessment of its impact on weight loss and quality of life is crucial.

• People with SO after LSG face slow weight loss, prolonged ideal weight attainment, and reduced quality of life, emphasizing the need for preoperative assessment and personalized rehabilitation.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shang-Guan, ZX., Lin, GT., Liu, ZY. et al. Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life after Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study. OBES SURG 34, 1479–1490 (2024). https://doi.org/10.1007/s11695-024-07146-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-024-07146-z

Keywords

Navigation